KR101561441B1 - Composition for preventing or treating periodontal disease comprising Solanum carolinense extract as effective component - Google Patents

Abstract

The present invention relates to an antimicrobial composition against periodontal bacteria comprising a Solanum carolinense extract as an active ingredient, a pharmaceutical composition for preventing or treating periodontal diseases comprising a Solanum carolinense extract as an active ingredient and a health functional food composition for preventing or alleviating periodontal diseases comprising a Solanum carolinense extract as an active ingredient.

Description

[0001] The present invention relates to a composition for preventing or treating periodontal disease,

More particularly, the present invention relates to a composition for preventing or treating periodontal disease, which comprises as an active ingredient, a composition for antibiosis against periodontal bacteria, And to a health functional food composition for preventing or ameliorating periodontal disease, which comprises, as an active ingredient, a pharmaceutical composition for preventing or treating periodontal disease,

Solanum carolinense L.) is a naturalized plant that has come from North America. The flower resembles an eggplant flower shape, and has a lot of thorns on its stem and leaf. Leaves and stems have sharp and sharp thorns, and the fruit is small beads and ripen in yellow. Flowers bloom in June ~ October, and there are 3 ~ 1 in the inflorescence from the side of stem. It is widely used in Asia and Europe. However, there are few studies on the physiological activity and functionality of.

Periodontitis is a chronic inflammatory disease caused by bacteria and toxins in the microbial plaque, which is caused by inflammation of the surrounding tissue of the tooth. Periodontal tissue that supports the tooth is gradually destroyed, causing the tooth to shake and eventually fall out. Periodontitis is an idiom and is often referred to as a periodontal disease. It is also called periodontal disease or periodontal disease. When periodontal disease occurs, the gingiva falls and the tooth root appears and the symptoms of syenin appear.

Dental medicine Various oral diseases including tooth decay, gingivitis and periodontal disease can be caused by various causes. The cause is divided into systemic cause and local cause, and the most important cause is local cause. The most important local cause is bacteria that reside in the mouth, that is, pathogenic microorganisms.

It is known in the human oral cavity that about 300 kinds of microorganisms are resident on the tooth surface, between the teeth and gums in the root portion, on the surface of the tongue, etc., and the presence of such microorganisms is considered to be caused by proper oral hygiene This is a normal phenomenon. However, if proper oral hygiene activities are not performed, various oral diseases such as tooth decay, halitosis, gingivitis and periodontal disease may be caused by pathogenic microorganisms among the above-mentioned microorganisms, and in severe cases, teeth may be lost.

More specifically, a pathogenic microorganism resident in the oral cavity attaches to the surface of the tooth and forms a bacterial population called a plaque after a few hours. At first, a pathogenic microorganism attaches However, as progressive progression occurs, plaque is formed on the surface of the tooth under the gingiva. When the plaque is formed on the tooth surface, the pathogenic microorganism produces an acid by using the sugar introduced into the oral cavity, and this acid may cause tooth decay by demineralizing the main ingredient of the tooth.

Microorganisms that play the most important role in causing oral diseases as mentioned above include Streptococcus mutans ( Streptococcus mutans) mutans ), the causative agent of periodontitis, Porphyromonas gingivalis ).

Conventionally, various kinds of antimicrobial agents including antibiotics having sterilization and bacteriostatic action against the microorganisms have been developed as inhibitors and remedies for cavity, periodontal disease or gingivitis. Conventional materials include fluorine and chlorine-containing compounds such as sodium copper chlorophyllin, sodium fluoride or benzethonium chloride, benzoic acid, , Allantoin, tocopheryl acetate, antiplasmic agents or antibiotics, and the like. However, in the case of the fluorine-chlorine-containing compound, safety of the human body is problematic. Antibiotics can cause systemic side effects, including diarrhea and vomiting, in the whole body, It is difficult to use it for a long period of time because it can induce homozygosity, so that it can be used only as a therapeutic agent. In addition, in the case of treatment by surgical treatment or mechanical therapy, there is a disadvantage that treatment is not easy.

Therefore, it is easy to prevent or treat as compared with surgical therapy or mechanical therapy, and there is no problem of tolerance or stability such as antibiotics even when used for a long time, and there is no problem of side effects such as a compound containing fluorine and chlorine components There is an urgent need to develop a composition for the prevention or treatment of oral diseases derived from natural materials, and there is an increasing demand for developing a composition capable of preventing or treating oral diseases from natural materials.

Korean Patent No. 0829045 discloses a composition for the prevention or treatment of periodontal disease, which contains a chewy gum extract as an active ingredient. Korean Patent No. 0605116 discloses a composition for preventing or treating periodontal disease, However, it differs from the composition for preventing or treating periodontal disease, which contains the extract of the present invention as an active ingredient.

SUMMARY OF THE INVENTION The present invention has been made in view of the above-mentioned needs, and the present inventors have found that Solanum carolinense extract showed antimicrobial activity against Porphyromonas gingivalis , a periodontal bacteria. Thus, the present invention has been completed.

In order to solve the above problems, the present invention provides an antimicrobial composition for periodontal bacteria containing Solanum carolinens as an active ingredient.

In addition, the present invention relates to the use of Solanum carolinense ) as an active ingredient. The present invention also provides a pharmaceutical composition for preventing or treating periodontal disease.

In addition, the present invention relates to the use of Solanum The present invention provides a health functional food composition for preventing or ameliorating periodontal disease, which contains, as an active ingredient, a carolinense extract.

Ghost of (Solanum according to the invention carolinense ) as an active ingredient is a Porphyromonas spp. gingivalis ), it can be used as a pharmaceutical composition for the prevention or treatment of periodontal disease, and as a health functional food composition for preventing or improving periodontal disease.

In order to achieve the object of the present invention, the present invention provides an antimicrobial composition for periodontal bacteria containing an extract of Solanum carolinense as an active ingredient.

In the antimicrobial composition of the present invention, the periodontitis bacteria may be selected from the group consisting of Porphyromonas gingivalis , Tannerella < RTI ID = 0.0 > forsythia , Fusobacterium < RTI ID = 0.0 > nucleatum ) and Actinobacillus ( Actinobacillus < RTI ID = 0.0 > actinomycetemcomitans ), and the like, preferably, but not limited to, Porphyromonas gingivalis .

In addition, in the antimicrobial composition of the present invention, the gibbsite extract may be an extract using leaves or stems of the plant, but the present invention is not limited thereto.

In addition, in the antimicrobial composition of the present invention, the gibbsite extract may be water, methanol, ethanol, propanol, butanol or a mixed solvent thereof, preferably a dried methanol extract of the gibbsite Specifically, the giblets cut into 2 ~ 3 cm were dried at 30 ~ 50 ℃ for 2 ~ 4 days, and then 75 ~ 85% (v / v) It may be one prepared by adding methanol, extracting it using an ultrasonic device, and filtering.

The present invention also provides a pharmaceutical composition for the prevention or treatment of periodontal disease, which contains an extract of the gibbsite extract as an active ingredient.

The term 'periodontal disease' is often referred to as a style, depending on the degree of disease gingivitis (gingivitis) and periodontitis (periodontitis) is divided into. It is a relatively light and fast-acting periodontal disease called gingivitis that is limited to gingiva or soft tissue, and it is called periodontitis when the inflammation progresses to the gums and the gums.

The extract of the present invention may comprise suitable carriers, excipients and diluents conventionally used in the manufacture of pharmaceutical compositions.

The pharmaceutical dosage forms of the extract of the present invention may be used in the form of their pharmaceutically acceptable salts, and may be used alone or in combination with other pharmaceutically active compounds as well as in suitable aggregates.

The extract according to the present invention may be formulated in the form of powders, granules, tablets, capsules, suspensions, emulsions, syrups, aerosols or the like, oral preparations, suppositories and sterilized injection solutions according to a conventional method have. Examples of carriers, excipients and diluents that can be included in the extract include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, acacia rubber, alginate, gelatin, calcium phosphate, calcium silicate, Various compounds or mixtures including cellulose, microcrystalline cellulose, polyvinylpyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oil. In the case of formulation, a diluent or excipient such as a filler, an extender, a binder, a wetting agent, a disintegrant, or a surfactant is usually used. Solid formulations for oral administration include tablets, pills, powders, granules, capsules and the like, which may contain at least one excipient such as starch, calcium carbonate, sucrose ), Lactose, gelatin and the like. In addition to simple excipients, lubricants such as magnesium stearate and talc are also used. Examples of the liquid preparation for oral administration include suspensions, solutions, emulsions, and syrups. In addition to water and liquid paraffin, simple diluents commonly used, various excipients such as wetting agents, sweeteners, fragrances, preservatives and the like may be included . Formulations for parenteral administration include sterilized aqueous solutions, non-aqueous solutions, suspensions, emulsions, freeze-dried preparations, and suppositories. Examples of the suspending agent include propylene glycol, polyethylene glycol, vegetable oil such as olive oil, injectable ester such as ethyl oleate, and the like. As a suppository base, witepsol, macrogol, tween 60, cacao paper, laurin, glycerogelatin and the like can be used.

The preferred dosage of the extract of the present invention varies depending on the condition and the weight of the patient, the degree of disease, the type of drug, the administration route and the period of time, but can be appropriately selected by those skilled in the art. However, for the desired effect, the extract of the present invention is preferably administered at 0.0001 to 100 mg / kg, preferably 0.001 to 100 mg / kg per day. The administration may be carried out once a day or divided into several times. The dose is not intended to limit the scope of the invention in any way.

The extract of the present invention can be administered to mammals such as rats, mice, livestock, humans and the like in various routes. All modes of administration may be expected, for example, by oral administration or by injection.

The present invention also provides a health functional food composition for preventing or ameliorating periodontal disease, which comprises an extract of Ganoderma Lucidum as an active ingredient.

The extract of the present invention has excellent antimicrobial activity against Porphyromonas gingivirus, which is a periodontal bacteria, and thus can be effectively used for preventing or improving periodontal diseases such as periodontitis.

When the extract of the present invention is used as a food additive, the extract may be directly added, used in combination with other food or food ingredients, and suitably used according to a conventional method. The amount of the active ingredient to be mixed can be suitably determined according to its intended use (prevention, health or therapeutic treatment). Generally, the extract of the present invention is added in an amount of not more than 15 parts by weight, preferably not more than 10 parts by weight, based on the raw material, in the production of food or beverage. However, in the case of long-term consumption intended for health and hygiene purposes or for health control purposes, the amount may be less than the above range, and since there is no problem in terms of safety, the active ingredient may be used in an amount exceeding the above range .

There is no particular limitation on the kind of the food. Examples of the food to which the above extract can be added include dairy products such as meat, sausage, bread, chocolate, candy, snack, confectionery, pizza, ramen noodle, gums, ice cream, various soups, drinks, tea, Alcoholic beverages, and vitamin complexes, all of which include health functional foods in a conventional sense.

Hereinafter, the present invention will be described in detail with reference to examples. However, the following examples are illustrative of the present invention, and the present invention is not limited to the following examples.

Manufacturing example  One: Goblins  Preparation of extract

Solanum carolinense L.) extracts were obtained from leaves and stems. The leaves and stems of Euphorbiaceae identified by the plant taxonomist were cut evenly into 2.54 cm using a cutting tool and then dried in a drying oven at 40 ° C for 3 days. About 500 g of plant dry weight was extracted with 80% methanol using an ultrasonic device. The liquid was passed through a membrane filter (0.2 μm), filtered, and the solvent was removed in a vacuum to leave a methanol extract. Through this process, the fibrin among the components of the goby goby can be filtered through the purification process, and the goby goby goby plant extract is a methanol extract mainly containing trace components of goby goby. All solvents used were analytical grade, purchased from Sigma-Aldrich (USA) or Merck (USA).

Experimental Example  1: Growth inhibition assay for causing periodontitis

The antimicrobial activity against the pathogenic bacteria of periodontal disease was examined. Briefly, 1 x 10 < ⁷ > cfu / ml of Porphyromonas gingivalis W83 (ATCC BAA-1703) was prepared in a 5 ml serum bottle, 0.6 mg / ml, respectively. After that, the cells were cultured at 37 ° C for 24 hours while maintaining the anaerobic state, and the growth inhibition rate of the pathogenic bacteria causing periodontal disease was analyzed. A total of 3 replicate experiments were performed, and each experiment was repeated 3 times.

Example  One: Goblins  Growth inhibition rate of the causative agent of periodontitis in the extract

Table 1 shows the antimicrobial activity effect of the methanol extract of the gibbsite on the periodontal bacteria. As a result, the growth inhibition rate was about 90% at the concentration of 0.6 ㎎ / ㎖ of extracts of Euphorbiaceae, and 100% at the concentration of 1.8 ㎎ / ㎖ and 94% and 3.6 ㎎ / ㎖, respectively. As a result, it was confirmed that the methanol extract of Goby beetle can be used for prevention or treatment of periodontal disease due to its high antimicrobial activity against periodontal bacteria.

Porphyromonas gingivalis growth inhibition rate (%) Extract concentration Growth inhibition rate (%) 0.6 mg / ml 89 ± 0.32 1.8 mg / ml 94 ± 0.44 3.6 mg / ml 100 ± 0.00

Claims (5)

An antimicrobial composition for Porphyromonas gingivalis containing Solanum carolinense in water, methanol, ethanol, propanol, butanol or a mixed solvent extract thereof as an active ingredient. delete delete Pharmacology for the prevention or treatment of periodontal disease caused by Porphyromonas gingivalis , which contains Solanum carolinense in water, methanol, ethanol, propanol, butanol or a mixed solvent extract thereof as an active ingredient Composition. A method for the prevention or amelioration of periodontal disease caused by Porphyromonas gingivalis containing water of dried Solanum carolinense , methanol, ethanol, propanol, butanol or a mixed solvent extract thereof as an active ingredient Functional food composition.